David Krempa - Oct 2, 2024 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ETON	Restricted Stock Units	Award	$0	+42.1K	+5.14%	$0.00	861K	Oct 2, 2024	Common Stock	42.1K		Direct	F1, F2

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
F2	The restricted stock units vest in four equal annual installments beginning October 2, 2025, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.

The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.